What is the long-term trend for Prestige Consumer Healthcare's repayments of notes payable?

Over 4 years (2022 to 2026), Prestige Consumer Healthcare's repayments of notes payable has grown at a -100.0% compound annual growth rate (CAGR), from $600M to $0.

Prestige Consumer Healthcare PBH Repayments Of Notes Payable

Repayments Of Notes Payable at other companies

American Assets TrustAAT

$0-100%

Century CommunitiesCCS

$9M+15.6%

Ondas, Inc. ONDS

$305K+4,107%

Ivanhoe ElectricIE

$9.82M+134%

RBC BearingsRBC

$200K0.0%

Keurig Dr PepperKDP

$7M-61.1%

Other financials

Income statement

See full

Revenue$281.6M-5.0%

Gross profit$146.3M-13.9%

Operating income$75.5M-14.6%

Net income$53.9M+7.6%

EPS (diluted)$1.13+11.9%

Balance sheet

See full

Cash & equivalents$63.9M-34.8%

Total debt$1.0B-0.2%

Total equity$1.9B+2.9%

Total assets$3.5B+2.7%

Cash flow

See full

Operating cash flow$42.8M-30.7%

CapEx$5.2M+49.8%

Free cash flow$37.6M-35.5%

Valuation

See full

Market cap$2.24B-34.1%

Profitability

See full

Gross margin54.7%-1.1pp

Operating margin28.4%-1.2pp

Net margin17.5%-1.4pp

FCF margin22.6%+1.3pp

Returns & leverage

See full

Return on equity10.2%-2.1pp

Debt / equity0.6×0.0×

Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfNotesPayable.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's repayments of notes payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prestige Consumer Healthcare's repayments of notes payable?: Prestige Consumer Healthcare (PBH) reported repayments of notes payable of $0 in Q1 2026.
What is the long-term trend for Prestige Consumer Healthcare's repayments of notes payable?: Over 4 years (2022 to 2026), Prestige Consumer Healthcare's repayments of notes payable has grown at a -100.0% compound annual growth rate (CAGR), from $600M to $0.